ISPOR - PCN228 - REAL-WORLD USE OF PEMBROLIZUMAB AND NIVOLUMAB FROM CLINICAL TRIALS TO MARKET LAUNCH- WHAT CAN BE LEARNED?

Full Text

PCN228 - REAL-WORLD USE OF PEMBROLIZUMAB AND NIVOLUMAB FROM CLINICAL TRIALS TO MARKET LAUNCH- WHAT CAN BE LEARNED?

Abstract

Authors

E. Bouee Benhamiche C. Le Bihan Benjamin M. Rocchi S. Negellen P.J. Bousquet

Back to Volume 21, Supplemental S3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now